Growth Metrics

Oruka Therapeutics (ORKA) Selling, General & Administrative (2010 - 2024)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 1.32 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -37.00 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.17 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 493.70 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -1.52 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 647.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 322.55 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 2.99 Mn
Mar 31, 2024 2.32 Mn
Dec 31, 2023 1.54 Mn
Sep 30, 2023 1.62 Mn
Jun 30, 2023 1.72 Mn
Mar 31, 2023 1.41 Mn
Dec 31, 2022 1.49 Mn
Sep 30, 2022 1.53 Mn
Jun 30, 2022 1.73 Mn
Mar 31, 2022 1.10 Mn
Dec 31, 2021 1.74 Mn
Sep 30, 2021 1.28 Mn
Jun 30, 2021 1.26 Mn
Mar 31, 2021 1.23 Mn
Dec 31, 2020 1.92 Mn
Sep 30, 2020 939,000.00
Jun 30, 2020 938,000.00
Mar 31, 2020 975,000.00
Dec 31, 2019 894,000.00
Sep 30, 2019 900,000.00
Jun 30, 2019 1.07 Mn
Mar 31, 2019 1.12 Mn
Dec 31, 2018 902,000.00
Sep 30, 2018 922,000.00
Jun 30, 2018 1.00 Mn
Mar 31, 2018 1.05 Mn
Dec 31, 2017 1.46 Mn
Sep 30, 2017 987,000.00
Jun 30, 2017 1.05 Mn
Mar 31, 2017 1.14 Mn
Dec 31, 2016 1.17 Mn
Sep 30, 2016 992,000.00
Jun 30, 2016 1.03 Mn
Mar 31, 2016 1.07 Mn
Dec 31, 2015 1.28 Mn
Sep 30, 2015 1.10 Mn
Jun 30, 2015 972,000.00
Mar 31, 2015 1.04 Mn
Dec 31, 2014 1.03 Mn
Sep 30, 2014 950,000.00
Jun 30, 2014 1.01 Mn
Mar 31, 2014 1.08 Mn
Dec 31, 2013 1.16 Mn
Sep 30, 2013 1.01 Mn
Jun 30, 2013 952,000.00
Mar 31, 2013 889,000.00
Dec 31, 2012 648,000.00
Sep 30, 2012 772,000.00
Jun 30, 2012 823,000.00
Mar 31, 2012 984,000.00
Dec 31, 2011 1.04 Mn
Sep 30, 2011 1.29 Mn
Jun 30, 2011 1.21 Mn
Mar 31, 2011 1.51 Mn
Dec 31, 2010 1.49 Mn
Sep 30, 2010 1.38 Mn
Jun 30, 2010 1.57 Mn